image credit: Adobe Stock

New therapy harnesses patients’ blood cells to fight tumors

April 10, 2023

Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient’s own tumors, could provide a new treatment option to cancer patients, potentially bypassing radiation therapies and harsh chemotherapy drugs.

For the first time, Northwestern University scientists have discovered it is possible to isolate a tumor’s attack cells non-invasively from blood, rather than from tumors. The finding opens the door for ACT to treat harder-to-reach cancer types and makes it a more viable option for hospitals.

Read More on World Pharma News